Medtronic bets IT enhancements will boost revenue

Medtronic ($MDT) has turned to an unlikely source to help boost its annual revenue--IT. The Wall Street Journal's Clint Boulton writes about the journey the medical device giant is taking to get there that began in earnest when Omar Ishrak became CEO in May. Company CIO Michael Hedges evaluated the company's IT and determined that improvements could help sort through hospital and patient reports more quickly regarding defective or damaged medical devices (in addition to boosting sales efforts by coordinating global reports). Medtronic sees the improvements as helping it compete with St. Jude Medical ($STJ) and Boston Scientific ($BSX), as well as enhancing compliance with the FDA's record handling requirements. Blog

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.